Clinical trial
Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL
NCT00187161 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00187161 |
|---|---|
| Title | Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL |
| Official title | Small Noncleaved Cell (SNCC), Non-Hodgkin Lymphoma (NHL), Large Cell NHL (B-Cell) and B-Cell Acute Lymphoblastic Leukemia (B-ALL) Study II |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Mature B-Cell |
| Intervention type | Drug |
| Interventions | Prednison, Vincristine, Cytarabine, Methotrexate, Etoposide, Cyclophosphamide, Doxorubicin |
| Enrollment | 68 |
| Start date | Nov 1, 1994 |
| Completion | Jan 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: